撤回声明：“血管紧张素IV衍生肽的促认知和突触生成作用依赖于肝细胞生长因子/c-Met系统的激活”[《药理学与实验治疗学杂志》351卷（2014年）第390 - 402页] - Suppr | 超能文献

Retraction notice to "The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System" [J Pharmacol Exp Ther 351 (2014) 390-402].

作者信息

Benoist Caroline C, Kawas Leen H, Zhu Mingyan, Tyson Katherine A, Stillmaker Lori, Appleyard Suzanne M, Wright John W, Wayman Gary A, Harding Joseph W

机构信息

Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington.

Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington; M(3) Biotechnology, Inc., Seattle, Washington.

出版信息

J Pharmacol Exp Ther. 2025 Apr;392(4):103567. doi: 10.1016/j.jpet.2025.103567.

DOI:10.1016/j.jpet.2025.103567

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Retraction notice to "The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System" [J Pharmacol Exp Ther 351 (2014) 390-402].撤回声明：“血管紧张素IV衍生肽的促认知和突触生成作用依赖于肝细胞生长因子/c-Met系统的激活”[《药理学与实验治疗学杂志》351卷（2014年）第390 - 402页]

J Pharmacol Exp Ther. 2025 Apr;392(4):103567. doi: 10.1016/j.jpet.2025.103567.

2

Notice of Concern: Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, and Harding JW (2014) The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System, , 351: 390-402; DOI: https://doi.org/10.1124/jpet.114.218735.关注通知：贝努瓦·CC、川崎·LH、朱·M、泰森·KA、斯蒂尔马克·L、阿普利亚德·SM、赖特·JW、韦曼·GA和哈丁·JW（2014年）血管紧张素IV衍生肽的促认知和突触生成作用依赖于肝细胞生长因子/c-Met系统的激活，《药理学与实验治疗学杂志》，351卷：390 - 402页；DOI：https://doi.org/10.1124/jpet.114.218735 。

J Pharmacol Exp Ther. 2021 Sep;378(3):311. doi: 10.1124/jpet.114.218735concern.

3

Retraction notice to "Development of Angiotensin IV Analogs as Hepatocyte Growth Factor/Met Modifiers" [J Pharmacol Exp Ther 340 (2012) 539-548].《血管紧张素IV类似物作为肝细胞生长因子/Met修饰剂的开发》的撤稿通知 [《药理学与实验治疗学杂志》340 (2012) 539 - 548]

J Pharmacol Exp Ther. 2025 Apr;392(4):103566. doi: 10.1016/j.jpet.2025.103566.

4

Retraction notice to "Mimics of the Dimerization Domain of Hepatocyte Growth Factor Exhibit Anti-Met and Anticancer Activity" [J Pharmacol Exp Ther 339 (2011) 509-518].撤回声明：“肝细胞生长因子二聚化结构域的模拟物具有抗Met和抗癌活性”[《药理学与实验治疗学杂志》339卷（2011年）第509 - 518页]

J Pharmacol Exp Ther. 2025 Apr;392(4):103568. doi: 10.1016/j.jpet.2025.103568.

5

Notice of Concern: Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, and Harding JW (2012) Development of Angiotensin IV Analogs as Hepatocyte Growth Factor/Met Modifiers, , 340: 539-548; DOI: https://doi.org/10.1124/jpet.111.188136.关注通知：川瓦斯·L·H、麦科伊·A·T、山本·B·J、赖特·J·W和哈丁·J·W（2012年）《血管紧张素IV类似物作为肝细胞生长因子/Met调节剂的开发》，《药理学与实验治疗学杂志》，340: 539 - 548；数字对象标识符：https://doi.org/10.1124/jpet.111.188136 。

J Pharmacol Exp Ther. 2021 Sep;378(3):314. doi: 10.1124/jpet.111.188136concern.

6

Notice of Concern: McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, and Harding JW (2013) Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive/Antidementia Agents, , 344: 141-154; DOI: https://doi.org/10.1124/jpet.112.199497.关注通知：麦科伊·AT、贝努瓦·CC、赖特·JW、卡瓦斯·LH、布勒-戈加雷·JM、朱·M、阿普利亚德·SM、韦曼·GA和哈丁·JW（2013年）。代谢稳定的血管紧张素IV类似物作为促认知/抗痴呆药物的评估，《药理学与实验治疗学杂志》，344: 141 - 154；DOI: https://doi.org/10.1124/jpet.112.199497 。

J Pharmacol Exp Ther. 2021 Sep;378(3):313. doi: 10.1124/jpet.112.199497concern.

7

The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system.血管紧张素IV衍生肽的促认知和突触生成作用依赖于肝细胞生长因子/c-甲硫氨酸受体系统的激活。

J Pharmacol Exp Ther. 2014 Nov;351(2):390-402. doi: 10.1124/jpet.114.218735. Epub 2014 Sep 3.

8

Notice of Concern: Kawas LH, Yamamoto BJ, Wright JW, and Harding JW (2011) Mimics of the Dimerization Domain of Hepatocyte Growth Factor Exhibit Anti-Met and Anticancer Activity, , 339: 509-518; DOI: https://doi.org/10.1124/jpet.111.185694.关注通知：川瓦斯·L·H、山本·B·J、赖特·J·W和哈丁·J·W（2011年）《肝细胞生长因子二聚化结构域的模拟物具有抗Met和抗癌活性》，《药理学与实验治疗学杂志》，339卷：509 - 518页；DOI：https://doi.org/10.1124/jpet.111.185694 。

J Pharmacol Exp Ther. 2021 Sep;378(3):312. doi: 10.1124/jpet.111.185694concern.

9

Retraction notice to "Mitigation of Nitrogen Mustard-Induced Skin Injury by the β-Blocker Carvedilol and Its Enantiomers" [J Pharmacol Exp Ther 388 (2024) 495-505].

J Pharmacol Exp Ther. 2025 Apr;392(4):103569. doi: 10.1016/j.jpet.2025.103569.

10

Notice of Retraction: Harada S, Yamazaki Y, and Tokuyama S (2013) Orexin-A Suppresses Postischemic Glucose Intolerance and Neuronal Damage through Hypothalamic Brain-Derived Neurotrophic Factor, , 344: 276-285; DOI: https://doi.org/10.1124/jpet.112.199604.撤稿通知：原田S、山崎Y和德山S（2013年）《食欲素A通过下丘脑源性神经营养因子抑制缺血后葡萄糖不耐受和神经元损伤》，《药理学与实验治疗学杂志》，344：276 - 285；DOI：https://doi.org/10.1124/jpet.112.199604 。

J Pharmacol Exp Ther. 2020 Nov;375(2):397. doi: 10.1124/jpet.112.199604retraction.